Deutsche Bank
SION

Deutsche Bank’s Sionna Therapeutics SION Stock Holding History

Deutsche Bank’s Portfolio SION Stock Details SION Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.35M Buy
53,353
+40,104
+303% +$1.6M ﹤0.01% 1813
2026
Q1 		$531K Buy
13,249
+3,220
+32% +$123K ﹤0.01% 2546
2025
Q4 		$413K Buy
10,029
+433
+5% +$16.4K ﹤0.01% 2670
2025
Q3 		$282K Hold
9,596
– – ﹤0.01% 2884
2025
Q2 		$166K Buy
+9,596
New +$126K ﹤0.01% 3052

Other funds holding SION

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Deutsche Bank's SION Position: Q2 2026 in Review

Deutsche Bank increased its Sionna Therapeutics (SION) stake by 303% in Q2 2026, buying an estimated $1.6M and bringing the position to 53,353 shares worth $2.35M. The position accounts for ﹤0.01% of the portfolio, ranked #1813.

Deutsche Bank first reported a position in SION in Q2 2025 and has held it in 5 quarters since. 146 funds tracked by Wall St. Rank hold SION as of Q2 2026.

  • Deutsche Bank held 53,353 shares of Sionna Therapeutics worth $2.35M as of Q2 2026.
  • Deutsche Bank bought 40,104 Sionna Therapeutics shares in Q2 2026, an estimated $1.6M.
  • Sionna Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #1813 holding.
  • Deutsche Bank first reported a position in Sionna Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 146 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.